Herpes simplex 2 vaccine: Began two Phase III trials

Chiron Corp. (CHIR) Product: Herpes simplex 2 vaccine with MF59 adjuvant Indication: Genital herpes Status: Began two Phase III trials. One trial will study the rate of infection in more that 1,800 ...